177 related articles for article (PubMed ID: 25135461)
1. Late toxicity of proton beam therapy for patients with the nasal cavity, para-nasal sinuses, or involving the skull base malignancy: importance of long-term follow-up.
Zenda S; Kawashima M; Arahira S; Kohno R; Nishio T; Tahara M; Hayashi R; Akimoto T
Int J Clin Oncol; 2015 Jun; 20(3):447-54. PubMed ID: 25135461
[TBL] [Abstract][Full Text] [Related]
2. Proton beam therapy for unresectable malignancies of the nasal cavity and paranasal sinuses.
Zenda S; Kohno R; Kawashima M; Arahira S; Nishio T; Tahara M; Hayashi R; Kishimoto S; Ogino T
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1473-8. PubMed ID: 20961697
[TBL] [Abstract][Full Text] [Related]
3. Outcomes and toxicities of definitive radiotherapy and reirradiation using 3-dimensional conformal or intensity-modulated (pencil beam) proton therapy for patients with nasal cavity and paranasal sinus malignancies.
Fan M; Kang JJ; Lee A; Fan D; Wang H; Kitpanit S; Fox P; Sine K; Mah D; McBride SM; Tsai CJ; Riaz N; Dunn LA; Sherman EJ; Michel L; Singh B; Ganly I; Wong RJ; Boyle JO; Cohen MA; Lee NY
Cancer; 2020 Jan; 126(9):1905-1916. PubMed ID: 32097507
[TBL] [Abstract][Full Text] [Related]
4. Particle beam radiation therapy for sinonasal malignancies: Single institutional experience at the Shanghai Proton and Heavy Ion Center.
Hu W; Hu J; Huang Q; Gao J; Yang J; Qiu X; Kong L; Lu JJ
Cancer Med; 2020 Nov; 9(21):7914-7924. PubMed ID: 32977357
[TBL] [Abstract][Full Text] [Related]
5. Phase II study of proton beam therapy as a nonsurgical approach for mucosal melanoma of the nasal cavity or para-nasal sinuses.
Zenda S; Akimoto T; Mizumoto M; Hayashi R; Arahira S; Okumura T; Sakurai H
Radiother Oncol; 2016 Feb; 118(2):267-71. PubMed ID: 26547102
[TBL] [Abstract][Full Text] [Related]
6. Outcome of T4 (International Union Against Cancer Staging System, 7th edition) or recurrent nasal cavity and paranasal sinus carcinoma treated with proton beam.
Fukumitsu N; Okumura T; Mizumoto M; Oshiro Y; Hashimoto T; Kanemoto A; Hashii H; Ohkawa A; Moritake T; Tsuboi K; Tabuchi K; Wada T; Hara A; Sakurai H
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):704-11. PubMed ID: 22099036
[TBL] [Abstract][Full Text] [Related]
7. Outcomes following proton therapy for Ewing sarcoma of the cranium and skull base.
Kharod SM; Indelicato DJ; Rotondo RL; Mailhot Vega RB; Uezono H; Morris CG; Bradfield S; Sandler ES; Bradley JA
Pediatr Blood Cancer; 2020 Feb; 67(2):e28080. PubMed ID: 31736243
[TBL] [Abstract][Full Text] [Related]
8. Intensity-modulated radiotherapy for tumors of the nasal cavity and paranasal sinuses: clinical outcomes and patterns of failure.
Wiegner EA; Daly ME; Murphy JD; Abelson J; Chapman CH; Chung M; Yu Y; Colevas AD; Kaplan MJ; Fischbein N; Le QT; Chang DT
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):243-51. PubMed ID: 22019239
[TBL] [Abstract][Full Text] [Related]
9. Brain injury after proton therapy or carbon ion therapy for head-and-neck cancer and skull base tumors.
Miyawaki D; Murakami M; Demizu Y; Sasaki R; Niwa Y; Terashima K; Nishimura H; Hishikawa Y; Sugimura K
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):378-84. PubMed ID: 19735866
[TBL] [Abstract][Full Text] [Related]
10. Impact of early radiological response evaluation on radiotherapeutic outcomes in the patients with nasal cavity and paranasal sinus malignancies.
Hojo H; Zenda S; Akimoto T; Kohno R; Kawashima M; Arahira S; Nishio T; Tahara M; Hayashi R; Sasai K
J Radiat Res; 2012 Sep; 53(5):704-9. PubMed ID: 22843360
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness analysis of proton beam therapy for treatment decision making in paranasal sinus and nasal cavity cancers in China.
Li G; Qiu B; Huang YX; Doyen J; Bondiau PY; Benezery K; Xia YF; Qian CN
BMC Cancer; 2020 Jun; 20(1):599. PubMed ID: 32590957
[TBL] [Abstract][Full Text] [Related]
12. Long-Term Outcomes After Proton Beam Therapy for Sinonasal Squamous Cell Carcinoma.
Russo AL; Adams JA; Weyman EA; Busse PM; Goldberg SI; Varvares M; Deschler DD; Lin DT; Delaney TF; Chan AW
Int J Radiat Oncol Biol Phys; 2016 May; 95(1):368-376. PubMed ID: 27084654
[TBL] [Abstract][Full Text] [Related]
13. Postoperative intensity-modulated radiation therapy for cancers of the paranasal sinuses, nasal cavity, and lacrimal glands: technique, early outcomes, and toxicity.
Hoppe BS; Wolden SL; Zelefsky MJ; Mechalakos JG; Shah JP; Kraus DH; Lee N
Head Neck; 2008 Jul; 30(7):925-32. PubMed ID: 18302261
[TBL] [Abstract][Full Text] [Related]
14. Proton therapy for skull-base chondrosarcoma, a single-institution outcomes study.
Holtzman AL; Rotondo RL; Rutenberg MS; Indelicato DJ; Mercado CE; Rao D; Tavanaiepour D; Morris CG; Louis D; Flampouri S; Mendenhall WM
J Neurooncol; 2019 May; 142(3):557-563. PubMed ID: 30827010
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcome after particle therapy for meningiomas of the skull base: toxicity and local control in patients treated with active rasterscanning.
El Shafie RA; Czech M; Kessel KA; Habermehl D; Weber D; Rieken S; Bougatf N; Jäkel O; Debus J; Combs SE
Radiat Oncol; 2018 Mar; 13(1):54. PubMed ID: 29587795
[TBL] [Abstract][Full Text] [Related]
16. Superselective high-dose cisplatin infusion with concomitant radiotherapy in patients with advanced cancer of the nasal cavity and paranasal sinuses: a single institution experience.
Homma A; Oridate N; Suzuki F; Taki S; Asano T; Yoshida D; Onimaru R; Nishioka T; Shirato H; Fukuda S
Cancer; 2009 Oct; 115(20):4705-14. PubMed ID: 19634162
[TBL] [Abstract][Full Text] [Related]
17. Long-term follow-up after proton beam therapy for pediatric tumors: a Japanese national survey.
Mizumoto M; Murayama S; Akimoto T; Demizu Y; Fukushima T; Ishida Y; Oshiro Y; Numajiri H; Fuji H; Okumura T; Shirato H; Sakurai H
Cancer Sci; 2017 Mar; 108(3):444-447. PubMed ID: 28004469
[TBL] [Abstract][Full Text] [Related]
18. Post-operative intensity-modulated radiotherapy for malignancies of the nasal cavity and paranasal sinuses.
Dirix P; Nuyts S; Vanstraelen B; Nulens A; Hermans R; Jorissen M; Vander Poorten V; Van den Bogaert W
Radiother Oncol; 2007 Dec; 85(3):385-91. PubMed ID: 17963908
[TBL] [Abstract][Full Text] [Related]
19. Dose distribution resulting from changes in aeration of nasal cavity or paranasal sinus cancer in the proton therapy.
Fukumitsu N; Ishikawa H; Ohnishi K; Terunuma T; Mizumoto M; Numajiri H; Aihara T; Okumura T; Tsuboi K; Sakae T; Sakurai H
Radiother Oncol; 2014 Oct; 113(1):72-6. PubMed ID: 25245554
[TBL] [Abstract][Full Text] [Related]
20. Proton therapy for pediatric and adolescent esthesioneuroblastoma.
Lucas JT; Ladra MM; MacDonald SM; Busse PM; Friedmann AM; Ebb DH; Marcus KJ; Tarbell NJ; Yock TI
Pediatr Blood Cancer; 2015 Sep; 62(9):1523-8. PubMed ID: 25820437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
